Human cytomegalovirus seroprevalence and titres in solid organ transplant recipients and transplant donors in Seoul, South Korea

Table 3 HCMV seropositive rates and anti-HCMV IgG titre by transplant organs in solid organ transplant recipients

Age (years)	Kidney	Liver	Lung	Heart	p-value
Age (years)	(n = 1436)	(n = 579)	(n = 69)	(n = 100)	p-value
≤ 40
Seropositive	478 (95.2)	57 (98.3)	15 (100)	34 (94.4)	0.716
Titre (aU/mL)	57.7 ± 36.6	65.3 ± 42.6	69.5 ± 44.4	51.1 ± 27.0	0.184
41–60
Seropositive	801 (100)	400 (99.8)	33 (100)	47 (97.9)	0.073
Titre (aU/mL)	60.7 ± 34.6^*†	81.3 ± 55.5^*	88.5 ± 72.3^†	66.4 ± 60.7	0.001
≥ 61
Seropositive	133 (100)	120 (100)	21 (100)	16 (100)	―
Titre (aU/mL)	59.9 ± 44.2^*	82.9 ± 56.3^*	90.3 ± 80.5	48.8 ± 27.4	0.001
Total
Age, year	44.9 ± 12.4^*†	52.3 ± 12.0^*‡	50.2 ± 13.0^†§	44.3 ± 17.3^‡§	<0.001
Seropositive	1412 (98.3)	577 (99.7)^a	69 (100.0)^a	97 (97.0)	0.024
Titre (aU/mL)	59.4 ± 36.1^*†	80.1 ± 54.5^*‡	84.3 ± 68.3^†§	58.1 ± 46.9^‡§	<0.001

Data are expressed as number (percent) or mean ± standard deviation. ^*†‡§p-value <0.05 between two groups in post-hoc tests by Bonferroni correction after ANOVA. ^aadjusted p < 0.05 between two groups using post-hoc analyses based on adjusted standardised residuals. Abbreviation: aU, arbitrary unit

ISSN: 1471-2334